# MIRA Pharmaceuticals, Inc. (MIRA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MIRA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -1.15M | $ -1.20M | $ 0 | $ 9.35M |
| 2025 | $ 0 | $ -10.69M | $ -4.77M | $ 0 | $ 10.39M |
| 2024 | $ 0 | $ -8.25M | $ -5.84M | $ 0 | $ 2.20M |
| 2023 | $ 0 | $ -12.96M | $ -6.09M | $ 5.1K | $ 4.37M |
| 2022 | $ 0 | $ -7.88M | $ -6.26M | $ 491.2K | $ -596.2K |
| 2021 | $ 0 | $ -67.7K | $ -19.5K | $ 0 | $ 0 |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.01 |
| Current Ratio | 82.16 |

## Other views

- [Metrics](https://sponda.capital/en/MIRA.md)
- [Charts](https://sponda.capital/en/MIRA/charts.md)
- [Compare](https://sponda.capital/en/MIRA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.